Nanjing Bioheng Biotech Co., Ltd.
7 clinical trials · Sponsor
◉ Watch Nanjing Bioheng Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases (NCT07596680) | Nanjing Bioheng Biotech Co., Ltd. | 2026-09-01 |
| A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM (NCT07142161) | Nanjing Bioheng Biotech Co., Ltd. | 2025-07-20 |
| Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases (NCT06775912) | Nanjing Bioheng Biotech Co., Ltd. | 2025-01-03 |
| Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases (NCT06548607) | Nanjing Bioheng Biotech Co., Ltd. | 2024-09-14 |
| A Study of RD06-04 in Patients With Active Autoimmune Diseases (NCT06548620) | Nanjing Bioheng Biotech Co., Ltd. | 2024-08-31 |
Track Nanjing Bioheng Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.